Top compounds associated with response to OR5T2


Feature Type Standardized
Nominal ANOVA
mRNA ATRA GDSC1000 pan-cancer AAC -0.0061 0.9
mRNA KHS101 CTRPv2 pan-cancer AAC -0.0065 0.9
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0057 0.9
mRNA SB-225002 CTRPv2 pan-cancer AAC -0.0054 0.9
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.0058 0.9
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0062 0.9
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.0061 0.9
mRNA PF-184 CTRPv2 pan-cancer AAC -0.0056 0.9
mRNA CIL70 CTRPv2 pan-cancer AAC 0.0081 0.9
mRNA ATRA CTRPv2 pan-cancer AAC 0.0058 0.9
Download CSV